Articles

Podcasts

Videos

Clinical

Rochelle P. Walensky, MD, MPH, signs off on the Centers for Disease Control and Prevention’s  (CDC) Advisory Committee on Immunization Practices’ (ACIP) recommendation for individuals 6 through 17 years of age.

CDC Director Endorses ACIP Recommendation for Moderna COVID-19 Vaccine for Children and Adolescents

Patients with a history of infection who were also vaccinated had the strongest protection, the data showed.

Against COVID-19, Both Natural and Vaccination-Mediated Protection Wane Over Time

Studies, advances, and authorizations continue in this paramount area within infectious disease.

Infectious Disease Vaccines: 5 Important Updates 

The CDC director endorsed the vote, and vaccines could be available to this young pediatric population by later this week.

CDC Panel Recommends mRNA COVID-19 Vaccines in Children 6 Months Through 5 years of Age

This past week has been extremely busy in infectious disease with a lot of vaccine news that could impact young children. In addition, GSK reported on its phase 3 study on its RSV vaccine for seniors.

Infectious Disease Update: June 17, 2022

Following VRBPAC recommendations earlier this week, both the Pfizer-BioNTech and Moderna COVID-19 vaccines were FDA-authorized for children as young as 6 months.

FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children 6 Months and Older

The FDA VRBPAC votes to recommend mRNA vaccines in youngest children; WHO moves to rename monkeypox; Anthony Fauci is diagnosed with COVID-19; and Pfizer stops recruiting for a Paxlovid trial.

Infectious Disease Update: June 15, 2022

Today, the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend both the Moderna and Pfizer-BioNTech COVID-19 vaccines for children as young as 6 months old.

FDA Vaccine Advisory Committee Recommends Moderna and Pfizer-BioNTech Vaccines for Everyone 6 Months and Older

The committee voted twice splitting the questions into younger children (6-11 years) and adolescent (12-17 years) cohorts due to different vaccine dosing amounts. 

FDA VRBPAC Votes to Recommend Moderna COVID-19 Vaccine in Children and Adolescents 6 Years Through 17 Years  

Sanofi and GSK’s booster vaccine candidate is modeled on the Beta COVID-19 variant, and increases Omicron-neutralizing antibody titers 40-fold.

COVID VACCINE RACE

Latest News